These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

702 related articles for article (PubMed ID: 23268613)

  • 21. Effects of adherence to ventilator-associated pneumonia treatment guidelines on clinical outcomes.
    Sakaguchi M; Shime N; Iguchi N; Kobayashi A; Takada K; Morrow LE
    J Infect Chemother; 2013 Aug; 19(4):599-606. PubMed ID: 23188167
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Time to Guideline-Based Empiric Antibiotic Therapy in the Treatment of Pneumonia in a Community Hospital: A Retrospective Review.
    Erwin BL; Kyle JA; Allen LN
    J Pharm Pract; 2016 Aug; 29(4):386-91. PubMed ID: 25601458
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Keeping it Simple: Impact of a Restrictive Antibiotic Policy for Ventilator-Associated Pneumonia in Trauma Patients on Incidence and Sensitivities of Causative Pathogens.
    Evans CR; Sharpe JP; Swanson JM; Wood GC; Fabian TC; Croce MA; Magnotti LJ
    Surg Infect (Larchmt); 2018 Oct; 19(7):672-678. PubMed ID: 30204541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of antibiotic treatment algorithms based on local ecology and respiratory surveillance cultures to restrict the use of broad-spectrum antimicrobial drugs in the treatment of hospital-acquired pneumonia in the intensive care unit: a retrospective analysis.
    De Bus L; Saerens L; Gadeyne B; Boelens J; Claeys G; De Waele JJ; Benoit DD; Decruyenaere J; Depuydt PO
    Crit Care; 2014 Jul; 18(4):R152. PubMed ID: 25030270
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of the duration of antibiotics on clinical events in patients with Pseudomonas aeruginosa ventilator-associated pneumonia: study protocol for a randomized controlled study.
    Bouglé A; Foucrier A; Dupont H; Montravers P; Ouattara A; Kalfon P; Squara P; Simon T; Amour J;
    Trials; 2017 Jan; 18(1):37. PubMed ID: 28114979
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ventilator-associated tracheobronchitis and pneumonia: thinking outside the box.
    Craven DE; Hjalmarson KI
    Clin Infect Dis; 2010 Aug; 51 Suppl 1():S59-66. PubMed ID: 20597674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Therapeutic Strategy for All Pneumonia Patients: A 3-Year Prospective Multicenter Cohort Study Using Risk Factors for Multidrug-resistant Pathogens to Select Initial Empiric Therapy.
    Maruyama T; Fujisawa T; Ishida T; Ito A; Oyamada Y; Fujimoto K; Yoshida M; Maeda H; Miyashita N; Nagai H; Imamura Y; Shime N; Suzuki S; Amishima M; Higa F; Kobayashi H; Suga S; Tsutsui K; Kohno S; Brito V; Niederman MS
    Clin Infect Dis; 2019 Mar; 68(7):1080-1088. PubMed ID: 30084884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An overview of guidelines for the management of hospital-acquired and ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria.
    Cillóniz C; Dominedò C; Torres A
    Curr Opin Infect Dis; 2019 Dec; 32(6):656-662. PubMed ID: 31567412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microbiological surveillance and antimicrobial stewardship minimise the need for ultrabroad-spectrum combination therapy for treatment of nosocomial infections in a trauma intensive care unit: an audit of an evidence-based empiric antimicrobial policy.
    Ramsamy Y; Muckart DJ; Han KS
    S Afr Med J; 2013 Mar; 103(6):371-6. PubMed ID: 23725954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment guidelines and outcomes of hospital-acquired and ventilator-associated pneumonia.
    Torres A; Ferrer M; Badia JR
    Clin Infect Dis; 2010 Aug; 51 Suppl 1():S48-53. PubMed ID: 20597672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A retrospective cohort study of the influence of time of hospital-acquired pneumonia onset on pathogen constitution].
    Hu BJ; Wei L; Zhang XZ; Tang YC; Ni YX; Li YM; Guo JQ; Hu YJ; Zhang KX; Yang L
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb; 28(2):112-6. PubMed ID: 15854394
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Empiric, broad-spectrum antibiotic therapy with an aggressive de-escalation strategy does not induce gram-negative pathogen resistance in ventilator-associated pneumonia.
    Hibbard ML; Kopelman TR; O'Neill PJ; Maly TJ; Matthews MR; Cox JC; Vail SJ; Quan AN; Drachman DA
    Surg Infect (Larchmt); 2010 Oct; 11(5):427-32. PubMed ID: 20818984
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Guideline-adherent initial intravenous antibiotic therapy for hospital-acquired/ventilator-associated pneumonia is clinically superior, saves lives and is cheaper than non guideline adherent therapy.
    Wilke M; Grube RF; Bodmann KF
    Eur J Med Res; 2011 Jul; 16(7):315-23. PubMed ID: 21813372
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determinants of prescription and choice of empirical therapy for hospital-acquired and ventilator-associated pneumonia.
    Rello J; Ulldemolins M; Lisboa T; Koulenti D; Mañez R; Martin-Loeches I; De Waele JJ; Putensen C; Guven M; Deja M; Diaz E;
    Eur Respir J; 2011 Jun; 37(6):1332-9. PubMed ID: 20847075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Understanding the Concept of Health Care-Associated Pneumonia in Lung Transplant Recipients.
    Palacio F; Reyes LF; Levine DJ; Sanchez JF; Angel LF; Fernandez JF; Levine SM; Rello J; Abedi A; Restrepo MI
    Chest; 2015 Aug; 148(2):516-522. PubMed ID: 25742187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hospital-acquired pneumonia in critically ill patients: factors associated with episodes due to imipenem-resistant organisms.
    Leroy O; d'Escrivan T; Devos P; Dubreuil L; Kipnis E; Georges H
    Infection; 2005 Jun; 33(3):129-35. PubMed ID: 15940413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Distribution of Multidrug-resistant Microorganisms and Treatment Status of Hospital-acquired Pneumonia/Ventilator-associated Pneumonia in Adult Intensive Care Units: a Prospective Cohort Observational Study.
    Chang Y; Jeon K; Lee SM; Cho YJ; Kim YS; Chong YP; Hong SB
    J Korean Med Sci; 2021 Oct; 36(41):e251. PubMed ID: 34697926
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High prevalence of multidrug-resistant nonfermenters in hospital-acquired pneumonia in Asia.
    Chung DR; Song JH; Kim SH; Thamlikitkul V; Huang SG; Wang H; So TM; Yasin RM; Hsueh PR; Carlos CC; Hsu LY; Buntaran L; Lalitha MK; Kim MJ; Choi JY; Kim SI; Ko KS; Kang CI; Peck KR;
    Am J Respir Crit Care Med; 2011 Dec; 184(12):1409-17. PubMed ID: 21920919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hospital-acquired pneumonia and ventilator-associated pneumonia: recent advances in epidemiology and management.
    Barbier F; Andremont A; Wolff M; Bouadma L
    Curr Opin Pulm Med; 2013 May; 19(3):216-28. PubMed ID: 23524477
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of a guideline for the management of ventilator-associated pneumonia based on local microbiologic findings and impact of the guideline on antimicrobial use practices.
    Dellit TH; Chan JD; Skerrett SJ; Nathens AB
    Infect Control Hosp Epidemiol; 2008 Jun; 29(6):525-33. PubMed ID: 18510462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.